Zobrazeno 1 - 10 of 2 333 pro vyhledávání: '"Ravassa S"'
1
Akademický článek
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial.
Autor: Yu YL; Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium., Siwy J; Mosaiques-Diagnostics GmbH, Hannover, Germany., An DW; Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium.; Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China., González A; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain., Hansen T; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium.; Steno Diabetes Center Copenhagen, the Capital Region of Denmark, Gentofte, Denmark., Latosinska A; Mosaiques-Diagnostics GmbH, Hannover, Germany., Pellicori P; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Ravassa S; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain., Mariottoni B; Department of Cardiology, Cortona Hospital, Arezzo, Italy., Verdonschot JA; Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands., Ahmed F; Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK., Petutschnigg J; Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité University Medicine Berlin, Berlin Institute of Health and German Center for Cardiovascular Research, Partner Site Berlin, Germany., Rossignol P; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Heymans S; Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands., Cuthbert JJ; Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK., Girerd N; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Clark AL; Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK., Verhamme P; Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium., Nawrot TS; Research Unit Environment and Health, KU Leuven Department of Public Health and Primary Care, University of Leuven, Leuven, Belgium.; Centre for Environmental Sciences, Hasselt University, Hasselt, Belgium., Janssens S; Research Unit Cardiology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium., Cleland JG; British Heart Foundation Centre of Research Excellence, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK., Zannad F; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Diez J; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain CIBERCV, Carlos III Institute of Health, Madrid, Spain., Mischak H; Mosaiques-Diagnostics GmbH, Hannover, Germany., Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France.; Cardiovascular R&D Centre UniC@rRISE, Department of Physiology and Cardiothoracic Surgery, Faculty of Medicine, University of Porto Portugal, Porto, Portugal.; Portugal % Heart Failure Clinics, Department of Internal Medicine, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia/Espinho, Portugal., Staessen JA; Non-Profit Research Association Alliance for the Promotion of Preventive Medicine (APPREMED), Mechelen, Belgium jan.staessen@appremed.org.; Department of Cardiovascular Medicine, Shanghai Key Laboratory of Hypertension, Shanghai Institute of Hypertension, State Key Laboratory of Medical Genomics, National Research Centre for Translational Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.; Biomedical Science Group, University of Leuven, Leuven, Belgium.
Publikováno v: Heart (British Cardiac Society) [Heart] 2024 Sep 16; Vol. 110 (19), pp. 1180-1187. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu
2
Akademický článek
Circulating biomarkers of myocardial remodelling: current developments and clinical applications.
Autor: López B; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Ravassa S; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., San José G; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Latasa I; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain., Losada-Fuentenebro B; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Tapia L; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Díez J; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain.; CIBERCV, Madrid, Spain., Bayés-Genís A; CIBERCV, Madrid, Spain.; University Hospital Germans Trias i Pujol and Universitat Autònoma de Barcelona, Badalona, Spain., González A; Program of Cardiovascular Disease, CIMA Universidad de Navarra, Pamplona, Spain amiqueo@unav.es.; IdiSNA, Pamplona, Spain.; CIBERCV, Madrid, Spain.; Department of Cardiology, Clínica Univarsidad de Navarra, Pamplona, Spain.
Publikováno v: Heart (British Cardiac Society) [Heart] 2024 Sep 16; Vol. 110 (19), pp. 1157-1163. Date of Electronic Publication: 2024 Sep 16.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Myocardial Interstitial Fibrosis in Hypertensive Heart Disease: From Mechanisms to Clinical Management.
Autor: González A; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Department of Pathology, Anatomy and Physiology, Universidad de Navarra, Pamplona, Spain (A.G.)., López B; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Ravassa S; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., San José G; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Latasa I; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.)., Butler J; Baylor Scott and White Research Institute, Dallas, TX (J.B.).; Department of Medicine, University of Mississippi, Jackson (J.B.)., Díez J; Program of Cardiovascular Disease, Centro de Investigación Médica Aplicada Universidad de Navarra (CIMA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Insitituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).; Center for Biomedical Research in Cardiovascular Diseases Network (CIBERCV), Carlos III Institute of Health, Madrid, Spain (A.G., B.L., S.R., G.S.J., I.L., J.D.).
Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Feb; Vol. 81 (2), pp. 218-228. Date of Electronic Publication: 2023 Dec 12.
Zobrazit plný text záznamu
7
Akademický článek
Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies.
Autor: Ravassa S; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., López B; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Treibel TA; Institute of Cardiovascular Science, University College London, UK; Barts Heart Centre, St Bartholomew's Hospital, London, UK., San José G; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Losada-Fuentenebro B; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Tapia L; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Bayés-Genís A; CIBERCV, Carlos III Institute of Health, Madrid, Spain; Servei de Cardiologia i Unitat d'Insuficiència Cardíaca, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain., Díez J; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain. Electronic address: jadimar@unav.es., González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain; CIBERCV, Carlos III Institute of Health, Madrid, Spain. Electronic address: amiqueo@unav.es.
Publikováno v: Molecular aspects of medicine [Mol Aspects Med] 2023 Oct; Vol. 93, pp. 101194. Date of Electronic Publication: 2023 Jun 27.
Zobrazit plný text záznamu
8
Akademický článek
Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.
Autor: Ravassa S; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain., López B; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Ferreira JP; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Girerd N; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Bozec E; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Pellicori P; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK., Mariottoni B; Department of Cardiology, Cortona Hospital, Arezzo, Italy., Cosmi F; Department of Cardiology, Cortona Hospital, Arezzo, Italy., Hazebroek M; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands., Verdonschot JAJ; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands., Cuthbert J; Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, UK., Petutschnigg J; Department of Internal Medicine and Cardiology Campus Virchow Klinikum, Charité University Medicine Berlin and German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Moreno MU; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain., Heymans S; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands., Staessen JA; Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen (APPREMED), Mechelen, Belgium.; Biomedical Sciences Group, Faculty of Medicine, University of Leuven, Leuven, Belgium., Pieske B; Department of Internal Medicine and Cardiology Campus Virchow Klinikum, Charité University Medicine Berlin and German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.; Berlin Institute of Health, Berlin, Germany., Edelmann F; Department of Internal Medicine and Cardiology Campus Virchow Klinikum, Charité University Medicine Berlin and German Centre for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany., Clark AL; Department of Cardiology, University of Hull, Castle Hill Hospital, Cottingham, UK., Cleland JGF; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK., Zannad F; Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU de Nancy, F-CRIN INI-CRCT, Nancy, France., Díez J; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain.; Departments of Nephrology and Cardiology, Clínica Universidad de Navarra, Pamplona, Spain., González A; Program of Cardiovascular Diseases, CIMA, Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
Publikováno v: European journal of heart failure [Eur J Heart Fail] 2022 Feb; Vol. 24 (2), pp. 321-331. Date of Electronic Publication: 2021 Dec 09.
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje